Up-regulation of mitogen-activated protein kinases ERK1/2 and MEK1/2 is associated with the progression of neurofibrillary degeneration in Alzheimer’s disease

Neuropathological stageing of Alzheimer-related changes.

Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123

Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology.

Grundke-Iqbal, I., Iqbal, K., Tung, Y. C., Quinlan, M., Wisniewski, H. M., & Binder, L. I. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.13.4913 · Cited by 3,676

Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease

Arriagada, P. V., Growdon, J. H., Hedley-Whyte, E. T., & Hyman, B. T. (1992) · Neurology · doi:10.1212/wnl.42.3.631 · Cited by 2,668

ERKs: A family of protein-serine/threonine kinases that are activated and tyrosine phosphorylated in response to insulin and NGF

Boulton, T. G., Nye, S. H., Robbins, D. J., Ip, N. Y., Radzlejewska, E., Morgenbesser, S. D., DePinho, R. A., Panayotatos, N., Cobb, M. H., & Yancopoulos, G. D. (1991) · Cell · doi:10.1016/0092-8674(91)90098-j · Cited by 1,876

Microtubule-associated protein tau. A component of Alzheimer paired helical filaments.

Grundke, I., Iqbal, K., Quinlan, M., Tung, Y. C., Zaidi, M. S., & Wisniewski, H. M. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)38495-8 · Cited by 1,780

Requirement for integration of signals from two distinct phosphorylation pathways for activation of MAP kinase

Anderson, N. G., Maller, J. L., Tonks, N. K., & Sturgill, T. W. (1990) · Nature · doi:10.1038/343651a0 · Cited by 1,064

A sequence of cytoskeleton changes related to the formation of neurofibrillary tangles and neuropil threads

Braak, F., Braak, H., & Mandelkow, E. (1994) · Acta Neuropathologica · doi:10.1007/bf00293315 · Cited by 769

DEFECTIVE BRAIN MICROTUBULE ASSEMBLY IN ALZHEIMER'S DISEASE

Iqbal, K., Zaidi, T., Wen, G. Y., Grundke, I., MERZ, P. A., Shaikh, S., Wisniewski, H., Alafuzoff, I. I., & Winblad, B. G. (1986) · The Lancet · doi:10.1016/s0140-6736(86)92134-3 · Cited by 737

Glycogen synthase kinase-3 induces Alzheimer's disease-like phosphorylation of tau: Generation of paired helical filament epitopes and neuronal localisation of the kinase

Hanger, D. P., Hughes, K., Woodgett, J. R., Brion, J.-P., & Anderton, B. H. (1992) · Neuroscience Letters · doi:10.1016/0304-3940(92)90774-2 · Cited by 737

Identification of normal and pathological aging in prospectively studied nondemented elderly humans

Dickson, D. W., Crystal, H. A., Mattiace, L. A., Masur, D. M., Blau, A. D., Davies, P., Yen, S.-H., & Aronson, M. K. (1992) · Neurobiology of Aging · doi:10.1016/0197-4580(92)90027-u · Cited by 643

Declining phosphatases underlie aging-related hyperphosphorylation of neurofilaments

Veeranna, Yang, D., Lee, J., Vinod, K. Y., Stavrides, P. H., Amin, N. D., Pant, H. C., & Nixon, R. A. (2009) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2009.12.001 · Cited by 46

Regulation of cyclin‐dependent kinase 5 and p53 by ERK1/2 pathway in the DNA damage‐induced neuronal death

Lee, J., & Kim, K. (2006) · Journal of Cellular Physiology · doi:10.1002/jcp.20899 · Cited by 49

Mechanistic/mammalian target of rapamycin: Recent pathological aspects and inhibitors

Abdel‐Maksoud, M. S., El–Gamal, M. I., Benhalilou, D. R., Ashraf, S., Mohammed, S. A., & Oh, C. (2018) · Medicinal Research Reviews · doi:10.1002/med.21535 · Cited by 45

Troglitazone, a peroxisome proliferator‐activated receptor‐γ agonist, decreases tau phosphorylation in CHOtau4R cells

d’Abramo, C., Ricciarelli, R., Pronzato, M. A., & Davies, P. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.03931.x · Cited by 46

Regulation of glycogen synthase kinase‐3β by products of lipid peroxidation in human neuroblastoma cells

Dozza, B., Smith, M. A., Perry, G. L., Tabaton, M., & Strocchi, P. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02413.x · Cited by 43

P2 receptor interaction and signalling cascades in neuroprotection

Miras‐Portugal, M. T., Queipo, M. J., Gil‐Redondo, J. C., Ortega, F., Gómez‐Villafuertes, R., Gualix, J., Delicado, E. G., & Pérez‐Sen, R. (2018) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2018.12.012 · Cited by 43

RKIP Regulates Neural Cell Apoptosis Induced by Exposure to Microwave Radiation Partly Through the MEK/ERK/CREB Pathway

Zuo, H., Lin, T., Wang, D., Peng, R., Wang, S., Gao, Y., Xu, X., Zhao, L., Wang, S., & Su, Z.-T. (2014) · Molecular Neurobiology · doi:10.1007/s12035-014-8831-5 · Cited by 39

Microtubules modulate melatonin receptors involved in phase‐shifting circadian activity rhythms: in vitro and in vivo evidence

Jarzynka, M. J., Passey, D. K., Johnson, D. A., Konduru, N. V., Fitz, N. F., Radio, N. M., Rasenick, M. M., Benloucif, S., Melan, M. A., & Witt‐Enderby, P. A. (2009) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2008.00644.x · Cited by 39

Low concentrations of aggregated β-amyloid induce neurite formation via the neurotrophin receptor p75

Susen, K., & Blöchl, A. (2005) · Journal of Molecular Medicine · doi:10.1007/s00109-005-0671-3 · Cited by 38

mTor Is a Signaling Hub in Cell Survival: A Mass-Spectrometry-Based Proteomics Investigation

Tang, Z., Baykal, A. T., Gao, H., Quezada, H. C., Zhang, H., Bereczki, E., Serhatlı, M., Baykal, B., Acıoğlu, Ç., Wang, S., et al. (2014) · Journal of Proteome Research · doi:10.1021/pr500192g · Cited by 37

Neuron-Specific Alterations in Signal Transduction Pathways associated with Alzheimer's Disease

Gerschütz, A., Heinsen, H., Grünblatt, E., Wagner, A. K., Bartl, J., Meißner, C., Fallgatter, A. J., Al‐Sarraj, S., Troakes, C., Ferrer, I., et al. (2014) · Journal of Alzheimer s Disease · doi:10.3233/jad-131280 · Cited by 37

Phosphorylation of soluble tau differs in Pick’s disease and Alzheimer’s disease brains

van Eersel, J., Bi, M., Ke, Y. D., Hodges, J. R., Xuereb, J. H., Gregory, G. C., Halliday, G. M., Götz, J., Kril, J. J., & Ittner, L. M. (2009) · Journal of Neural Transmission · doi:10.1007/s00702-009-0293-y · Cited by 38

Cellular and molecular mechanisms of pathological tau phosphorylation in traumatic brain injury: implications for chronic traumatic encephalopathy

Donison, N. S., Palik, J., Volkening, K., & Strong, M. J. (2025) · Molecular Neurodegeneration · doi:10.1186/s13024-025-00842-z · Cited by 42

Epigenetic regulators of neuronal ferroptosis identify novel therapeutics for neurological diseases: HDACs, transglutaminases, and HIF prolyl hydroxylases

Rroji, O., Kumar, A., Karuppagounder, S. S., & Ratan, R. R. (2020) · Neurobiology of Disease · doi:10.1016/j.nbd.2020.105145 · Cited by 36

Nuclear ERK1/2 signaling potentiation enhances neuroprotection and cognition via Importinα1/KPNA2

Indrigo, M. T., Morella, I., Orellana, D. I., d’Isa, R., Papale, A., Parra, R., Gurgone, A., Lecca, D., Cavaccini, A., Tigaret, C. M., et al. (2023) · EMBO Molecular Medicine · doi:10.15252/emmm.202215984 · Cited by 35

Tau in MAPK Activation

Leugers, C. J., Koh, J. Y., Hong, W., & Lee, G. S. (2013) · Frontiers in Neurology · doi:10.3389/fneur.2013.00161 · Cited by 34

Zinc-induced anti-apoptotic effects in SH-SY5Y neuroblastoma cells via the extracellular signal-regulated kinase 1/2

An, W., Pei, J.-J., Nishimura, T., Winblad, B. G., & Cowburn, R. F. (2005) · Molecular Brain Research · doi:10.1016/j.molbrainres.2004.11.010 · Cited by 35

Mechanism of okadaic acid‐induced neuronal death and the effect of estrogens

Yi, K. D., Covey, D. F., & Simpkins, J. W. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05805.x · Cited by 35

Reduced miR-512 and the Elevated Expression of Its Targets cFLIP and MCL1 Localize to Neurons With Hyperphosphorylated Tau Protein in Alzheimer Disease

Mezache, L., Mikhail, M., Garofalo, M., & Nuovo, G. J. (2015) · Applied immunohistochemistry & molecular morphology · doi:10.1097/pai.0000000000000147 · Cited by 34

Insights into the Pathophysiology of Alzheimer’s Disease and Potential Therapeutic Targets: A Current Perspective

Kumaran, K. R., Yunusa, S., Perimal, E. K., Wahab, H. A., Müller, C. P., & Hassan, Z. (2022) · Journal of Alzheimer s Disease · doi:10.3233/jad-220666 · Cited by 39

Usp14 Deficiency Increases Tau Phosphorylation without Altering Tau Degradation or Causing Tau-Dependent Deficits

Jin, Y. N., Chen, P., Watson, J. A., Walters, B. J., Phillips, S. E., Green, K., Schmidt, R. E., Wilson, J. A., Johnson, G. V. W., Roberson, E. D., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0047884 · Cited by 34

Raf Kinase Inhibitor Protein Attenuates Ischemic-Induced Microglia Cell Apoptosis and Activation Through NF-κB Pathway

Su, L., Zhang, R., Chen, Y., Zhu, Z., & Ma, C. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000464119 · Cited by 33

Alzheimer risk gene product Pyk2 suppresses tau phosphorylation and phenotypic effects of tauopathy

Brody, A. H., Nies, S. H., Guan, F., Smith, L. M., Mukherjee, B., Salazar, S. A., Lee, S., Lam, T. K. T., & Strittmatter, S. M. (2022) · Molecular Neurodegeneration · doi:10.1186/s13024-022-00526-y · Cited by 36

Distribution, levels and phosphorylation of Raf‐1 in Alzheimer's disease

Mei, M., Su, B., Harrison, K. H., Chao, M. P., Siedlak, S., Previll, L. A., Jackson, L., Cai, D., & Zhu, X.-W. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04174.x · Cited by 34

A Novel Perspective on Tau in Alzheimers Disease

Bonda, D., Castellani, R. J., Zhu, X., Nunomura, A., Lee, H., Perry, G. L., & Smith, M. A. (2011) · Current Alzheimer Research · doi:10.2174/156720511796717131 · Cited by 32

Dissociation of Akt/PKB and ribosomal S6 kinase signaling markers in a transgenic mouse model of Alzheimer’s disease

Damjanac, M., Rioux Bilan, A., Paccalin, M., Pontcharraud, R., Fauconneau, B., Hugon, J., & Page, G. (2008) · Neurobiology of Disease · doi:10.1016/j.nbd.2007.09.008 · Cited by 32

Protein farnesylation is upregulated in Alzheimer’s human brains and neuron-specific suppression of farnesyltransferase mitigates pathogenic processes in Alzheimer’s model mice

Jeong, A., Cheng, S., Zhong, R., Bennett, D. A., Bergö, M. O., & Li, L. (2021) · Acta Neuropathologica Communications · doi:10.1186/s40478-021-01231-5 · Cited by 31

Effects of apoE on neuronal signaling and APP processing in rodent brain

Hoe, H.-S., Pocivavsek, A., Dai, H., Chakraborty, G., Harris, D. C., & Rebeck, G. W. (2006) · Brain Research · doi:10.1016/j.brainres.2006.07.035 · Cited by 30

DHCR24 Knockdown Induces Tau Hyperphosphorylation at Thr181, Ser199, Ser262, and Ser396 Sites via Activation of the Lipid Raft-Dependent Ras/MEK/ERK Signaling Pathway in C8D1A Astrocytes

Mai, M., Guo, X., Huang, Y. M., Zhang, W., Xu, Y., Zhang, Y., Bai, X., Wu, J., & Zu, H. (2022) · Molecular Neurobiology · doi:10.1007/s12035-022-02945-w · Cited by 28

Oncogenic Pathways in Neurodegenerative Diseases

Varela, L., & García-Rendueles, M. E. R. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23063223 · Cited by 30

Signalling Pathways Implicated in Alzheimer′s Disease Neurodegeneration in Individuals with and without Down Syndrome

Martínez‐Cué, C., & Rueda, N. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21186906 · Cited by 26

Protriptyline improves spatial memory and reduces oxidative damage by regulating NFκB-BDNF/CREB signaling axis in streptozotocin-induced rat model of Alzheimer’s disease

Tiwari, V., Mishra, A., Singh, S., Mishra, S. K., Sahu, K. K., Parul, P., Kulkarni, M. J., Shukla, R., & Shukla, S. (2021) · Brain Research · doi:10.1016/j.brainres.2020.147261 · Cited by 28

Heparan Sulfate Proteoglycans (HSPGs) Serve as the Mediator Between Monomeric Tau and Its Subsequent Intracellular ERK1/2 Pathway Activation

Song, L., Oseid, D. E., Wells, E. A., Coaston, T. N., & Robinson, A. S. (2022) · Journal of Molecular Neuroscience · doi:10.1007/s12031-021-01943-2 · Cited by 28

Patients with Alzheimer’s Disease May Be Particularly Susceptible to Adverse Effects of Statins

Algotsson, A., & Winblad, B. G. (2004) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000076342 · Cited by 25

Proteasome inhibition induces stress kinase dependent transport deficits — Implications for Alzheimer's disease

Agholme, L., Nath, S., Domert, J., Marcusson, J. O., Kågedal, K., & Hallbeck, M. (2013) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2013.11.001 · Cited by 25

Biased M1 muscarinic receptor mutant mice show accelerated progression of prion neurodegenerative disease

Scarpa, M., Molloy, C., Jenkins, L., Strellis, B., Budgett, R. F., Hesse, S., Dwomoh, L., Marsango, S., Tejeda, G. S., Rossi, M., et al. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2107389118 · Cited by 25

15-Deoxy-delta12,14-prostaglandin J2, a neuroprotectant or a neurotoxicant?

Koh, S., Jung, B., Song, C. W., Kim, Y., Kim, Y. S., & Kim, S. H. (2005) · Toxicology · doi:10.1016/j.tox.2005.08.015 · Cited by 25

Proteomic alterations of brain subcellular organelles caused by low-dose copper exposure: implication for Alzheimer’s disease

Yu, H., Wang, D., Zou, L., Zhang, Z., Xu, H., Zhu, F., Ren, X., Xu, B., Yuan, J., Liu, J., et al. (2018) · Archives of Toxicology · doi:10.1007/s00204-018-2163-6 · Cited by 25

Emodin Protects SH-SY5Y Cells Against Zinc-Induced Synaptic Impairment and Oxidative Stress Through the ERK1/2 Pathway

Chen, Q., Lai, C., Chen, F., Ding, Y., Zhou, Y., Su, S., Ni, R., & Tang, Z. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.821521 · Cited by 23

The identification of raft‐derived tau‐associated vesicles that are incorporated into immature tangles and paired helical filaments

Nishikawa, T., Takahashi, T., Nakamori, M., Hosomi, N., Maruyama, H., Miyazaki, Y., Izumi, Y., & Matsumoto, M. (2015) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12288 · Cited by 23

Endogenous β-amyloid peptide synthesis modulates cAMP response element-regulated gene expression in PC12 cells

Echeverrı́a, V., Ducatenzeiler, A., Chen, C. H., & Cuello, A. C. (2005) · Neuroscience · doi:10.1016/j.neuroscience.2005.06.057 · Cited by 24

Measurement of ERK 1/2 in CSF from Patients with Neuropsychiatric Disorders and Evidence for the Presence of the Activated Form

Klafki, H., Lewczuk, P., Kamrowski-Kruck, H., Maler, J., Müller, K., Peters, O., Heuser, I., Jessen, F., Popp, J., Frölich, L., et al. (2009) · Journal of Alzheimer's Disease · doi:10.3233/jad-2009-1167 · Cited by 23

Novel Synthetic Coumarin‐Chalcone Derivative (E)‐3‐(3‐(4‐(Dimethylamino)Phenyl)Acryloyl)‐4‐Hydroxy‐2H‐Chromen‐2‐One Activates CREB‐Mediated Neuroprotection in Aβ and Tau Cell Models of Alzheimer’s Disease

Chiu, Y., Lin, T., Chen, C., Lin, C., Teng, Y.-S., Lin, C., Sun, Y., Hsieh‐Li, H. M., Su, M., Lee‐Chen, G., et al. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/3058861 · Cited by 22

JNK signaling pathway regulates sorbitol-induced Tau proteolysis and apoptosis in SH-SY5Y cells by targeting caspase-3

Catalina, M. O., Bermejo, M. C., Argent, R., Alonso, J. C., Centeno, F., & Lorenzo, M. J. V. (2017) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2017.11.004 · Cited by 23

Neurosteroid metabolites of testosterone and progesterone differentially inhibit ERK phosphorylation induced by amyloid β in SH-SY5Y cells and primary cortical neurons

Mendell, A. L., Chung, B. Y. T., Creighton, C. E., Kalisch, B. E., Bailey, C. D. C., & MacLusky, N. J. (2018) · Brain Research · doi:10.1016/j.brainres.2018.02.023 · Cited by 24

Patient-Derived Fibroblasts With Presenilin-1 Mutations, That Model Aspects of Alzheimer’s Disease Pathology, Constitute a Potential Object for Early Diagnosis

López-Toledo, G., Silva‐Lucero, M., Herrera‐Díaz, J., García, D.-E., Arias‐Montaño, J., & Cárdenas‐Aguayo, M. D. C. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.921573 · Cited by 20

Sub-chronic oral cinnamaldehyde treatment prevents scopolamine-induced memory retrieval deficit and hippocampal Akt and MAPK dysregulation in male mice

Kazerouni, A., Nazeri, M., Karimzadeh, A., SoukhakLari, R., Moezi, L., Pirsalami, F., & Moosavi, M. (2020) · Neurological Research · doi:10.1080/01616412.2019.1709142 · Cited by 21

Inhibition of 5α Reductase Impairs Cognitive Performance, Alters Dendritic Morphology and Increases Tau Phosphorylation in the Hippocampus of Male 3xTg-AD Mice

Mendell, A. L., Creighton, S. D., Wilson, H. A., Jardine, K. H., Isaacs, L., Winters, B. D., & MacLusky, N. J. (2020) · Neuroscience · doi:10.1016/j.neuroscience.2020.01.011 · Cited by 21

Amyloid-β Protein Precursor Regulates Phosphorylation and Cellular Compartmentalization of Microtubule Associated Protein Tau

Nizzari, M., Barbieri, F., Gentile, M. T., Passarella, D., Caorsi, C., Diaspro, A., Taglialatela, M., Pagano, A., Colucci-D'Amato, L., Florio, T., et al. (2012) · Journal of Alzheimer's Disease · doi:10.3233/jad-2011-101590 · Cited by 21

The testosterone metabolite 3α-androstanediol inhibits oxidative stress-induced ERK phosphorylation and neurotoxicity in SH-SY5Y cells through an MKP3/DUSP6-dependent mechanism

Mendell, A. L., & MacLusky, N. J. (2018) · Neuroscience Letters · doi:10.1016/j.neulet.2018.12.012 · Cited by 23

Advanced Glycation End-Product Precursor Methylglyoxal May Lead to Development of Alzheimer’s Disease

Li, W. Y., Lee, C. Y., Lee, K. M., Zhang, G., Lü, A., & Yue, K. K. M. (2022) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s382927 · Cited by 19

Pharmacological inhibition of PTEN attenuates cognitive deficits caused by neonatal repeated exposures to isoflurane via inhibition of NR2B-mediated tau phosphorylation in rats

Tan, L., Chen, X., Wang, W., Zhang, J., Li, S., Zhao, Y., Wang, J., & Luo, A. (2016) · Neuropharmacology · doi:10.1016/j.neuropharm.2016.11.008 · Cited by 19

Tau interacts with SHP2 in neuronal systems and in Alzheimer's disease brains

Kim, Y., Liu, G., Leugers, C. J., Mueller, J. D., Francis, M. B., Hefti, M. M., Schneider, J. A., & Lee, G. S. (2019) · Journal of Cell Science · doi:10.1242/jcs.229054 · Cited by 19

Hyperphosphorylation of tau and neurofilaments and activation of CDK5 and ERK1/2 in PTEN-deficient cerebella

Nayeem, N., Kerr, F., Naumann, H., Linehan, J., Lovestone, S., & Brandner, S. (2007) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2006.11.014 · Cited by 19

Astrocytes Derived from Familial and Sporadic Alzheimer’s Disease iPSCs Show Altered Calcium Signaling and Respond Differently to Misfolded Protein Tau

Brezováková, V., Syková, E., & Jadhav, S. (2022) · Cells · doi:10.3390/cells11091429 · Cited by 19

Modifying Rap1-signalling by targeting Pde6δ is neuroprotective in models of Alzheimer’s disease

Dumbacher, M., Dooren, T. V., Princen, K., Witte, K. D., Farinelli, M., Lievens, S., Tavernier, J. H., Dehaen, W., Wera, S., Winderickx, J., et al. (2018) · Molecular Neurodegeneration · doi:10.1186/s13024-018-0283-3 · Cited by 18

Memantine Differentially Regulates Tau Phosphorylation Induced by Chronic Restraint Stress of Varying Duration in Mice

Liu, Y., Cao, L., Zhang, X., Liang, Y., Xu, Y., & Zhu, C. (2019) · Neural Plasticity · doi:10.1155/2019/4168472 · Cited by 18

Methamphetamine exposure upregulates the amyloid precursor protein and hyperphosphorylated tau expression: The roles of insulin signaling in SH-SY5Y cell line

Chen, L., Zhou, L., Yu, P., Fang, F., Jiang, L., Fei, J., Xiao, H., & Wang, J. (2019) · The Journal of Toxicological Sciences · doi:10.2131/jts.44.493 · Cited by 18

Dysregulated Protein Phosphorylation as Main Contributor of Granulovacuolar Degeneration at the First Stages of Neurofibrillary Tangles Pathology

Andrés‐Benito, P., Carmona, M., Pirla, M. J., Torrejón-Escribano, B., del Rı́o, J. A., & Ferrer, I. (2021) · Neuroscience · doi:10.1016/j.neuroscience.2021.10.023 · Cited by 18

Angelica tenuissima Nakai Ameliorates Cognitive Impairment and Promotes Neurogenesis in Mouse Model of Alzheimer’s Disease

Choi, M., Lee, Y., & Cho, S. (2017) · Chinese Journal of Integrative Medicine · doi:10.1007/s11655-017-2812-2 · Cited by 18

Selenium positively affects the proteome of 3 × Tg‐AD mice cortex by altering the expression of various key proteins: unveiling the mechanistic role of selenium in AD prevention

Iqbal, J., Zhang, K., Jin, N., Zhao, Y., Liu, Q., Ni, J., & Shen, L. (2018) · Journal of Neuroscience Research · doi:10.1002/jnr.24309 · Cited by 18

Beneficial Effects of Sideritis scardica and Cichorium spinosum against Amyloidogenic Pathway and Tau Misprocessing in Alzheimer’s Disease Neuronal Cell Culture Models

Chalatsa, I., Arvanitis, D. A., Mikropoulou, E. V., Giagini, A. T., Papadopoulou‐Daifoti, Z., Aligiannis, N., Halabalaki, M., Tsarbopoulos, A., Skaltsounis, A., & Sanoudou, D. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-170862 · Cited by 17

Trametinib activates endogenous neurogenesis and recovers neuropathology in a model of Alzheimer’s disease

Kim, M., Kim, M. J., Lee, C., Lee, J., Kim, S. S., Hong, S., Kim, H. T., Seo, J., Yoon, K., & Han, S. (2023) · Experimental & Molecular Medicine · doi:10.1038/s12276-023-01073-2 · Cited by 17

Inclusion Body Myositis: A View from the Caenorhabditis elegans Muscle

Rebolledo, D. L., Minniti, A. N., Grez, P. M., Fadić, R., Kohn, R. E., & Inestrosa, N. C. (2008) · Molecular Neurobiology · doi:10.1007/s12035-008-8041-0 · Cited by 19

Raf Inhibitors as Therapeutic Agents Against Neurodegenerative Diseases

Burgess, S., & Echeverrı́a, V. (2010) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/187152710790966632 · Cited by 17

A review on synthetic inhibitors of dual-specific tyrosine phosphorylation-regulated kinase 1A (DYRK1A) for the treatment of Alzheimer’s disease (AD)

Gehlot, P., Pathak, R., Kumar, S., Choudhary, N. K., & Vyas, V. K. (2024) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2024.117925 · Cited by 18

Three-way interaction model to trace the mechanisms involved in Alzheimer’s disease transgenic mice

Khayer, N., Marashi, S., Mirzaie, M., & Goshadrou, F. (2017) · PLoS ONE · doi:10.1371/journal.pone.0184697 · Cited by 16

Role of the p62 Protein in the Formation of Neuropathological Cytoplasmic Inclusions

Kuusisto, E. (2004) · Cited by 16

Magnetic resonance investigation of conformational responses of tau protein to specific phosphorylation

Lasorsa, A., Merzougui, H., Cantrelle, F., Sicoli, G., Dupré, E., Hanoulle, X., Belle, V., Smet‐Nocca, C., & Landrieu, I. (2023) · Biophysical Chemistry · doi:10.1016/j.bpc.2023.107155 · Cited by 14

Oral supplementation with Leu-Ile, a hydrophobic dipeptide, prevents the impairment of memory induced by amyloid beta in mice via restraining the hyperphosphorylation of extracellular signal-regulated kinase

Alkam, T., Nitta, A., Furukawa‐Hibi, Y., Niwa, M., Mizoguchi, H., Yamada, K., & Nabeshima, T. (2010) · Behavioural Brain Research · doi:10.1016/j.bbr.2010.02.028 · Cited by 15

Raf kinase inhibitor protein regulates oxygen-glucose deprivation-induced PC12 cells apoptosis through the NF-κB and ERK pathways

Su, L., Du, H., Dong, X., Zhang, X., & Lou, Z. (2016) · Journal of Clinical Biochemistry and Nutrition · doi:10.3164/jcbn.15-128 · Cited by 15

The ZiBuPiYin recipe regulates proteomic alterations in brain mitochondria-associated ER membranes caused by chronic psychological stress exposure: Implications for cognitive decline in Zucker diabetic fatty rats

Xu, H., Zhou, W., Zhan, L., Sui, H. X., Zhang, L., Zhao, C., & Lu, X. (2020) · Aging · doi:10.18632/aging.103894 · Cited by 15

Design, Synthesis, and Preliminary Evaluation of [68Ga]Ga-NOTA-Insulin as a PET Probe in an Alzheimer’s Disease Mouse Model

Taubel, J., Nelson, N. R., Bansal, A., Curran, G. L., Wang, L., Wang, Z., Berg, H. M., Vernon, C. J., Min, H.-K. P., Larson, N. B., et al. (2022) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.2c00126 · Cited by 16

Hsp90 co-chaperone degradation combined with antioxidation nanostrategy to rescue tauopathy-induced Alzheimer’s disease

Tang, Y., Zhao, D., Yang, F., Pang, G., Sun, Z., Chang, J. K., & Dou, Y. (2021) · Chemical Engineering Journal · doi:10.1016/j.cej.2021.134352 · Cited by 15

Emerging Putative Associations between Non-Coding RNAs and Protein-Coding Genes in Neuropathic Pain: Added Value from Reusing Microarray Data

Raju, H. B., Tsinoremas, N. F., & Capobianco, E. (2016) · Frontiers in Neurology · doi:10.3389/fneur.2016.00168 · Cited by 14

Key network approach reveals new insight into Alzheimer's disease

Schluesener, J. K., Zhu, X., Schluesener, H. J., Wang, G., & Ao, P. (2014) · IET Systems Biology · doi:10.1049/iet-syb.2013.0047 · Cited by 13

ERK activation and expression of neuronal cell cycle markers in the hippocampus after entorhinal cortex lesion

Hernández‐Ortega, K., & Arias, C. (2012) · Journal of Neuroscience Research · doi:10.1002/jnr.23106 · Cited by 13

Tau Protein and Zebrafish Models for Tau-Induced Neurodegeneration

Ding, Y., Lei, L., Lai, C., & Tang, Z. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-180917 · Cited by 13

Regulation of microtubule-associated proteins, protein kinases and protein phosphatases during differentiation of SY5Y cells

Haque, N., Gong, C., Sengupta, A., Iqbal, K., & Grundke, I. (2004) · Molecular Brain Research · doi:10.1016/j.molbrainres.2004.07.001 · Cited by 13

Okadaic acid inhibits the trichostatin A-mediated increase of human CYP46A1 neuronal expression in a ERK1/2-Sp3-dependent pathway

Nunes, M. J., Moutinho, M., Milagre, I., Gama, M. J., & Rodrigues, E. (2012) · Journal of Lipid Research · doi:10.1194/jlr.m027680 · Cited by 12

Vascular endothelial growth factor isoforms differentially protect neurons against neurotoxic events associated with Alzheimer’s disease

Alalwany, R. H., Hawtrey, T. J., Morgan, K., Morris, J. C., Donaldson, L. F., & Bates, D. O. (2023) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2023.1181626 · Cited by 11

Overactivated mitogen-activated protein kinase by anisomycin induces tau hyperphosphorylation.

Wang, Q., Zhang, J.-Y., Liu, S. J., & Li, H. L. (2008) · PubMed · Cited by 11

Familial amyloid polyneuropathy in Portugal: New genes modulating age‐at‐onset

Santos, D., Coelho, T., Alves‐Ferreira, M., Sequeiros, J., Mendonça, D. M., Alonso, I. D. C. M. P., Lemos, C., & Sousa, A. (2016) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.380 · Cited by 11

Oligomer β-amyloid Induces Hyperactivation of Ras to Impede NMDA Receptor-Dependent Long-Term Potentiation in Hippocampal CA1 of Mice

Wang, Y., Shi, Z., Zhang, Y., Yan, J., Yu, W., & Chen, L. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.595360 · Cited by 11

Modulation of BDNF/TrkB Signalling Pathway in Alzheimer’s Disease: Mechanistic Insights and the Role of Stem Cell Therapy

Harun, Z. Z., Azhar, A. A., Kim, Y. J., Ibrahim, F. W., Ng, M. H., Tan, J. K., & Lokanathan, Y. (2025) · Biomedicines · doi:10.3390/biomedicines13122931 · Cited by 10

AR12 increases BAG3 expression which is essential for Tau and APP degradation via LC3-associated phagocytosis and macroautophagy

Dent, P., Booth, L. A., Roberts, J. L., Poklepovic, A. S., Martinez, J., Cridebring, D., & Reiman, E. M. (2022) · Aging · doi:10.18632/aging.204337 · Cited by 11

Evolving significance of kinase inhibitors in the management of Alzheimer's disease

Ansari, M. M., Sahu, S. K., Singh, T. G., Singh, S. R. J., & Kaur, P. (2024) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2024.176816 · Cited by 9

Identifying Complex Biological Interactions based on Categorical Gene Expression Data

Goertzel, B., Pennachin, C. L., Coelho, L. D. S., & Mudado, M. (2006) · IEEE Congress on Evolutionary Computation (CEC) · doi:10.1109/cec.2006.1688477 · Cited by 9

Specific phosphorylation of microtubule-associated protein 2c by extracellular signal–regulated kinase reduces interactions at its Pro-rich regions

Plucarová, J., Jansen, S., Narasimhan, S., Laníková, A., Lewitzky, M., Feller, S. M., & Žı́dek, L. (2022) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2022.102384 · Cited by 8

Activation of Amyloid Precursor Protein Processing by Growth Factors is Dependent on Ras GTPase Activity

Amigoni, L., Ceriani, M., Belotti, F., Minopoli, G., & Martegani, E. (2010) · Neurochemical Research · doi:10.1007/s11064-010-0343-8 · Cited by 8

Pathological Calcium Signaling in Traumatic Brain Injury and Alzheimer’s Disease: From Acute Neuronal Injury to Chronic Neurodegeneration

Neuschmid, S., Schallerer, C., Ehrlich, B. E., & McGuone, D. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26189245 · Cited by 8

Unearthing nature's remedy: An exploration into Lycopodium's medicinal and therapeutic potential

Niinuma, S. A., Khudair, A. D., Habib, H., Khudair, A. D., Mackenzie, G., Atkin, S. L., & Butler, A. E. (2024) · Applied Materials Today · doi:10.1016/j.apmt.2024.102197 · Cited by 8

ELK1 inhibition alleviates amyloid pathology and memory decline by promoting the SYVN1-mediated ubiquitination and degradation of PS1 in Alzheimer’s disease

Yi, L., Li, J., He, Y., Wang, J., Wang, M., Guo, S., Luo, M., Wu, B., Xu, M., Tian, Q., et al. (2025) · Experimental & Molecular Medicine · doi:10.1038/s12276-025-01455-8 · Cited by 11

Rac1 and Akt Exhibit Distinct Roles in Mediating Aβ-Induced Memory Damage and Learning Impairment

Cheng, K., Chen, Y., Wu, C., Lee, W.-P., Cheung, C. H. A., & Chiang, H. (2021) · Molecular Neurobiology · doi:10.1007/s12035-021-02471-1 · Cited by 7

Protective effects of 2,4-dinitrophenol in okadaic acid-induced cellular model of Alzheimer's disease

Cardoso, S., Carvalho, C., Correia, S. C., & Moreira, P. I. (2024) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2024.167222 · Cited by 6

Emerging Roles of Signal Transduction Pathways in Neurodegenerative Diseases. Hunting New Possible Therapeutic Molecular Targets

Vasco, V. R. L. (2023) · OBM Geriatrics · doi:10.21926/obm.geriatr.2302234 · Cited by 6

Biomarker identification for diagnosis of Alzheimer's disease

Pelech, S. (2008) · Expert Opinion on Medical Diagnostics · doi:10.1517/17530059.2.5.577 · Cited by 6

Life-span influences of apoE4 on CNS function

Teter, B. (2006) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2006.06.028 · Cited by 6

Molecular Modeling of Tau Proline-Directed Protein Kinase (PDPK) Inhibitors

Navarro‐Retamal, C., & Caballero, J. (2017) · Neuromethods · doi:10.1007/978-1-4939-7404-7_13 · Cited by 6

Localization of the mitogen activated protein kinase ERK2 in Alzheimer's disease neurofibrillary tangles and senile plaque neurites.

Trojanowski, J., Mawal-Dewan, M., Schmidt, M., Martin, J. A., & Lee, V. M. (1993) · Brain Research · doi:10.1016/0006-8993(93)91286-2 · Cited by 91

Distribution, levels, and activation of MEK1 in Alzheimer's disease

Zhu, X.-W., Sun, Z., Lee, H.-G., Siedlak, S., Perry, G., & Smith, M. A. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01820.x · Cited by 60

Phosphorylated Map Kinase (ERK1, ERK2) Expression is Associated with Early Tau Deposition in Neurones and Glial Cells, but not with Increased Nuclear DNA Vulnerability and Cell Death, in Alzheimer Disease, Pick's Disease, Progressive Supranuclear Palsy and Corticobasal Degeneration

Ferrer, I., Blanco, R., Carmona, M., Ribera, R., Goutan, E., Puig, B., Rey, M. J., Cardozo, A., Viñals, F., & Ribalta, T. (2001) · Brain Pathology · doi:10.1111/j.1750-3639.2001.tb00387.x · Cited by 239

P3‐025: Chronic inhibition of the MEK/ERK pathway fails to delay disease progression in a transgenic animal model of tauopathy

Bose, S., Cavallini, A., Murray, T. K., Baschirotto, L., Czilli, D. L., Cella, C. V., Ward, M., Hanmer, J. M., Sims, H., Eberle, E. L., et al. (2012) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2012.05.1243

MAP Kinase Signaling Cascade Dysfunction Specific to Alzheimer's Disease in Fibroblasts

Zhao, W.-Q., Ravindranath, L., Mohamed, A. S., Zohar, O., Chen, G. H., Lyketsos, C. G., Etcheberrigaray, R., & Alkon, D. L. (2002) · Neurobiology of Disease · doi:10.1006/nbdi.2002.0520 · Cited by 62